The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The NO-ALS Study: A Trial of Nicotinamide/Pterostilbene Supplement in ALS.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04562831
Recruitment Status : Recruiting
First Posted : September 24, 2020
Last Update Posted : September 25, 2023
Sponsor:
Collaborator:
Elysium Health
Information provided by (Responsible Party):
Haukeland University Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 31, 2025
Estimated Study Completion Date : August 31, 2025